Reducing lipid peroxidation attenuates stress-induced susceptibility to herpes simplex virus type 1-Reference-Cited by-同舟云学术

Reducing lipid peroxidation attenuates stress-induced susceptibility to herpes simplex virus type 1

Published:2023-05-16 Issue:9 Volume:44 Page:1856-1866
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Weng Jing-yu,Chen Xin-xing,Wang Xiao-hua,Ye Hui-er,Wu Yan-ping,Sun Wan-yang,Liang Lei,Duan Wen-jun,Kurihara Hiroshi,Huang Feng,Sun Xin-xin,Ou-Yang Shu-hua,He Rong-rong,Li Yi-fang

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.nature.com/articles/s41401-023-01095-6.pdf

Reference54 articles.

1. Marcocci ME, Napoletani G, Protto V, Kolesova O, Piacentini R, Li Puma DD, et al. Herpes simplex virus-1 in the brain: the dark side of a sneaky infection. Trends Microbiol. 2020;28:808–20.

2. Singh N, Tscharke DC. Herpes simplex virus latency is noisier the closer we look. J Virol. 2020;94:e01701-19.

3. De Chiara G, Piacentini R, Fabiani M, Mastrodonato A, Marcocci ME, Limongi D, et al. Recurrent herpes simplex virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice. PLoS Pathog. 2019;15:e1007617.

4. Piret J, Boivin G. Immunomodulatory strategies in herpes simplex virus encephalitis. Clin Microbiol Rev. 2020;33:e00105-19.

5. Bello-Morales R, Andreu S, Lopez-Guerrero JA. The role of herpes simplex virus type 1 infection in demyelination of the central nervous system. Int J Mol Sci. 2020;21:5026.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phospholipid peroxidation in macrophage confers tumor resistance by suppressing phagocytic capability towards ferroptotic cells;Cell Death & Differentiation;2024-08-05

2. Small Animal Models to Study Herpes Simplex Virus Infections;Viruses;2024-06-27

3. Exploration of the in vitro Antiviral Effects and the Active Components of Changyanning Tablets Against Enterovirus 71;Drug Design, Development and Therapy;2024-03